Standout Papers
Immediate Impact
5 by Nobel laureates 26 standout
Citing Papers
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Sami Ibrahimi being referenced
Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary Analysis of the Randomized, Phase 3 Transform Study
2022
Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sami Ibrahimi | 258 | 145 | 60 | 32 | 363 | |
| Pim Mutsaers | 242 | 164 | 36 | 29 | 337 | |
| Alessandro Crotta | 256 | 109 | 45 | 24 | 346 | |
| Pratyush Giri | 314 | 232 | 83 | 28 | 411 | |
| Reid W. Merryman | 251 | 223 | 60 | 43 | 403 | |
| Max J. Gordon | 112 | 194 | 160 | 41 | 334 | |
| Anna Johnston | 108 | 123 | 60 | 37 | 325 | |
| Mariana Bastos‐Oreiro | 154 | 110 | 62 | 51 | 326 | |
| Moritz Bewarder | 113 | 96 | 48 | 42 | 321 | |
| Sandra P. Susanibar-Adaniya | 161 | 126 | 50 | 27 | 301 | |
| P. Nelli | 209 | 53 | 56 | 29 | 372 |
All Works
Login with ORCID to disown or claim papers
Loading papers...